| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
| SOCS3 |
O14543
|
suppressor of cytokine signaling 3
|
Enzyme modulator
|
0.75 |
0.434 |
0.808 |
| GRAP2 |
O75791
|
GRB2 related adaptor protein 2
|
|
1.5E-04 |
0.394 |
0.923 |
| AHSA1 |
O95433
|
activator of HSP90 ATPase activity 1
|
|
1.00 |
0.396 |
0.923 |
| IL33 |
O95760
|
interleukin 33
|
|
8.3E-10 |
0.409 |
0.885 |
| TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
| LTA |
P01374
|
lymphotoxin alpha
|
Signaling
|
0.20 |
0.434 |
0.885 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
| RAF1 |
P04049
|
Raf-1 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.85 |
0.418 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |